Merck (MRK) Tops Q2 EPS by 12c; Raises Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $150.42 +0.62%
Revenue Growth %: +0.2%
Financial Fact:
Income Before Taxes: 10.82B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +0.2%
Financial Fact:
Income Before Taxes: 10.82B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of ($2.06), $0.12 better than the analyst estimate of ($2.18). Revenue for the quarter came in at $15 billion versus the consensus estimate of $14.43 billion.
GUIDANCE:
Merck sees FY2023 EPS of $2.95-$3.05, versus the consensus of $2.60. Merck sees FY2023 revenue of $58.6-59.6 billion, versus the consensus of $53.2 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
